sas rtf 控制

《sas rtf 控制》由会员上传分享，免费在线阅读，更多相关内容在行业资料-天天文库。

1、SUGI31DataPresentationPaper089-31ConstructingStackTableswithMagic%GluePlus(AnotherUser-DefinedMacroforCreatingStackTables)LeiZhang,CelgeneCorporation,GeorgeLi,AmgenInc.ABSTRACTAsacompositetable,astacktableismadeupofavaryingnumberofchildtablesthatareplacedoneontopofanotherwithout

2、anygaps.Unlikearegulartablethathasafixednumberofcolumnsthroughouttherows,atypicalstacktableallowseachofitschildtablestohaveitsownnumberofcolumnsandheadersandeachcanvaryitssize,layoutandstyleseparately.Astacktablehencegivesamuchgreaterfreedomandcreativitytothedatapresentationthan

3、aregulartabledoes.Stacktablesarecommonlyusedincomplexreportsbecauseoftheireffectiveintegrationofstatisticalresultsfrommultiplesourcesandflexiblepresentationsofvariousaspectsofconcerns.Inthispaper,weextendthemethodintroducedin[1]andpresentanothermacrocalled%GluePlusthatcanassembl

4、emultipleseparatetablesinaRTFfileintoasinglestacktable.ThenewmacroisimplementedbytakingadvantageofthepowerofMicrosoftscriptingtechnologyviatheSASunnamedpipemechanism.Basedonthe%GluePlus,animprovedprogrammingframeworkisprovidedforcreatingallkindsofstacktablessystematicallywithase

5、riesofDataSteps,ProcTemplateandProcReportSteps.Acompleteexampleispresentedattheendtodemonstratethepowerfulnessandflexibilityofthetechniquedescribedinthispaper.INTRODUCTIONAstacktableisacompositetablethatconsistsofanarbitrarynumberofchildtablesthatareseamlesslyplacedoneontopofano

6、ther.Itiswidelyusedincomplexreportsbecauseoftheireffectiveintegratedpresentationsofvarioussummarydata.Beforewediscussabouthowtoconstructastacktable,let’stakealookatFigure1,astacktablewiththreechildtables.AnalysisofAverageChangeFromBaselineinT4(µg/dL)TreatmentPeriodChildtable1Ave

7、rageChangefromBaselineBaselineLS95%CIforLS†TreatmentGroupNMeanSDMeanMeanDrugA1143.80.32-0.01(-0.04,0.00)DrugB1153.70.28-0.03(-0.08,0.01)Placebo1133.80.30.02(-0.00,0.08)Childtable2Between-treatmentComparisonsfromANOVAModelDifferenceinLS%95CIforComparisonMeansDifferencep-valueDrug

8、Avs.DrugB-0.07(-0.14,-0.02)<0.001DrugBvs.Placeb